Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Net Margin (2016)

Rocket Pharmaceuticals' Net Margin history spans 2 years, with the latest figure at 1368.11% for Q3 2018.

  • For Q3 2018, Net Margin changed N/A year-over-year to 1368.11%; the TTM value through Jun 2019 reached 9917.35%, changed N/A, while the annual FY2015 figure was 1750.98%, 86485.0% up from the prior year.
  • Net Margin for Q3 2018 was 1368.11% at Rocket Pharmaceuticals, down from 4248.95% in the prior quarter.
  • Across five years, Net Margin topped out at 4817.22% in Q1 2016 and bottomed at 1368.11% in Q3 2018.